Medicare updates oral Rx demonstration
Pfizer's Somavert (pegvisomant) for treatment of acromegaly and Baxter's Mesnex (mesna) for reduction of ifosfamide-induced hemorrhagic cystitis will be reimbursed by the Medicare Part B replacement drug demonstration under an 1updated list of covered drugs. The original list of drugs included thirteen for oncology and fourteen for other indications (2"The Pink Sheet" June 28, 2004, p. 23)...
You may also be interested in...
Tamoxifen and thalidomide will be covered under the Medicare Part B oral drug replacement demonstration project, the Centers for Medicare & Medicaid Services said in announcing the start of the project June 24
When asked about an inspector general report that found hospitals are struggling with tests and resources, and are looking to the federal government to help facilitate more efficient distribution of medical devices to fight the COVID-19 crisis, President Trump attacked the report as a political hit from an Obama holdover.
Japanese medical device manufacturer Terumo Corp. promoted senior management execs; MiMedx Group, developer of human placental tissue allografts, raised exec to CFO; and more.